Jay R. Luly - Feb 13, 2023 Form 4/A - Amendment Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
President and CEO, Director
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Feb 13, 2023
Transactions value $
-$1,086,587
Form type
4/A - Amendment
Date filed
2/15/2023, 08:42 PM
Date Of Original Report
Feb 15, 2023
Previous filing
Dec 19, 2022
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Award $0 +23K +2.91% $0.00 811K Feb 13, 2023 Direct F1, F2
transaction ENTA Common Stock Award $0 +29.1K +3.59% $0.00 840K Feb 13, 2023 Direct F1, F3
transaction ENTA Common Stock Tax liability -$1.09M -20.6K -2.45% $52.77 820K Feb 13, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to correct an administrative error in the reported number of securities granted and the amount of securities beneficially owned following the transactions.
F2 Represents shares of Enanta common stock issued under a performance share unit ("PSU") award granted on December 18, 2020 that vested as a result of the achievement of a research and development milestone in calendar 2022 as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 13, 2023.
F3 Represents shares of Enanta common stock issued under a relative total stockholder return unit ("rTSRU") award granted to the reporting person on December 18, 2020 that was subject to performance-vesting restrictions based on the relative total stockholder return of Enanta's common stock in relation to the total stockholder return of the component companies in the Nasdaq Biotech Index over a two-year period. The performance level was determined by the Compensation Committee of Enanta's Board of Directors and the rTSRU settled with the issuance of the shares of Enanta common stock on February 13, 2023.
F4 Represents the number of shares of common stock automatically forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU and rTSRU awards.